Selpercatinib in Early-StageRETFusion–Positive Non–Small-Cell Lung Cancer

Post time 3 day(s) ago

journal：New England Journal of Medicine

Authors：Yi-Long Wu; Maximilian Hochmair; Yi Yang; Xue-Ning Yang; Masahiro Tsuboi; Luis Paz-Ares; James Chih-Hsin Yang; Lin Wu; Hye Ryun Kim; Damian T. Rieke; Melissa Johnson; Benjamin Besse; Nivedita Sharma; Patricia Maeda; Patrick Peterson; Boris Kin Lin; Bente Frimodt-Moller; Jonathan Goldman; Alexander Drilon

Published date：--

DOI：10.1056/nejmoa2602628

PDF link：http://www.nejm.org/doi/pdf/10.1056/NEJMoa2602628

Article link：https://doi.org/10.1056/nejmoa2602628

Article Source：Massachusetts Medical Society。

Remark：

Post time 3 day(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[NEJM] Selpercatinib in Early-StageRETFusion–Positive Non–Small-Cell Lung Cancer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Selpercatinib in Early-StageRETFusion–Positive Non–Small-Cell Lung Cancer Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Selpercatinib in Early-StageRETFusion–Positive Non–Small-Cell Lung Cancer